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ABSTRACT 
Fear memory and learning cause behavioural patterns such as fight or flight responses, which increase survival 
probability, but unfit processing of fear memory and learning can lead to maladaptive behaviours and maladies 
such as phobias, Post-Traumatic Stress Disorder (PTSD) and anxiety disorders. The growing prevalence of these 
maladies shows the need to quest novel methods for their treatment. We used anodal transcranial direct current 
stimulation (tDCS) on the right frontal region as a precondition neuromodulator and arachidonylcyclopropyla-
mide (ACPA), a selective CB1 cannabinoid receptor agonist, as a fear memory impairing agent to assess their ef-
fects on contextual and auditory fear conditioning (reliable model for fear studies). Right frontal anodal tDCS 
(0.2 mA for. 20 minutes) 24 hours before the train did not alter contextual and auditory learning and memory in 
short-term (24 hrs after the training phase). Moreover, intraperitoneal pre-train injection of ACPA (0.1 mg/kg) 
alone, decreased both contextual and auditory learning and memory in short- but not long-term. Right frontal an-
odal tDCS improved short-term contextual fear memory in subthreshold doses of ACPA. On the other hand, 
right frontal anodal tDCS in long-term improved (lower doses of ACPA) and restored (higher doses of ACPA) 
both fear memories. These findings showed that, aforementioned approach could cause durable learning and 
memory improvements. Also this combined modality could be useful for fear extinction training and maladies 
which inflict amnesia. 
 
Keywords:tDCS, ACPA, preconditioning, fear memory, memory enhancement, learning acceleration 
 
 
 
 
INTRODUCTION 
Fear memory and learning are essential 
abilities, that animals and humans benefit 
from, to evade dangers of their environment. 
When these fear responses become excessive 
(by unfit processing of an aversive stimulus), 
maladies like panic disorders, phobias, 
PTSD and anxiety disorders may occur. Sta-
tistics have shown that 4.7 % of adult Amer-
icans suffer from a life time panic disorder, 
EXCLI Journal 2017;16:1-13 – ISSN 1611-2156 
Received: October 08, 2016, accepted: December 05, 2016, published: January 02, 2017 
 
 
2 
also 12.1 % have life time social phobias and 
6.8 % bear life time PTSD; moreover, 
28.8 % endure any kind of anxiety disorder. 
These prevalence and their treatment ex-
penses, for instance during. 2010 in Europe 
alone, an estimated of 74.4 billion Euros 
were spent to treat anxiety disorders (Layton 
and Krikorian, 2001; Olesen et al., 2012), 
motivated us to do more research in this field 
to find a new effective treatment. 
The fear causing stimulus is evaluated by 
endocannabinoid signalling and by this eval-
uation, the proper behavioural responses, 
which are necessary for existence, homeosta-
sis and stress resilience are exerted, any flaw 
in this signalling system can lead to the psy-
chiatric disorder (Lutz et al., 2015). Endo-
cannabinoids also have vital roles in main-
taining emotional homeostasis (Marco and 
Viveros, 2009) as well as excluding the un-
pleasant memories (Marsicano et al., 2002). 
Most of endocannabinoid brain signalling 
are through G-protein coupled CB1 receptors 
(Caballero and Tseng, 2012), which high 
concentration of them are present in prefron-
tal cortex, hippocampus and amygdala. It 
seems that these receptors are important in 
modulating learning and memory (Castellano 
et al., 2003;Marsicano and Kuner, 
2008;Marsicano et al., 2002), also CB1 ago-
nists can help recalling and consolidating 
fear extinction memory (Abush and Akirav, 
2010; Das et al., 2013; Rabinak et al., 2013). 
Moreover, CB1 and CB2 cannabinoid recep-
tor agonist (WIN55212-2) in infralimbic re-
gion facilitates the fear extinc-
tion;cannabinoid receptors are also involved 
in adaptation to repellent conditions (Lin et 
al., 2009), furthermore, the intraperitoneal 
injection of WIN55212-2 can facilitate fear 
extinction and can also improve spatial 
memory (Pamplona et al., 2006). Also, CB1 
receptor inadequacy induce fear extinction 
deterioration (Marsicano et al., 2002). Infu-
sion of CP55,940 a ppotent, non-selective 
cannabinoid receptor agonist, in both in-
fralimbic and CA1 areas in rats brain, induc-
es the long-lasting disruption of fear memory 
reconsolidation and causes the reduction in 
freezing response (Santana et al., 2016). Be-
sides, we can boost the synaptic plasticity in 
both rodents and humans by stimulating the 
CB1 receptors (Mori et al., 2014), in addi-
tion, the CB1 receptor deficiency increases 
the contextual fear memory and also can 
change hippocampal synaptic plasticity, re-
vealing the essential role of endocannabinoid 
signalling in learning and memory (Jacob et 
al., 2012). Modulation of endocannabinoid 
(eCB) system can be considered as a novel 
direction towards finding a treatment for 
anxiety-related disorders with least adverse 
effects of cannabinoids (Chhatwal et al., 
2005; Patel and Hillard, 2006). Other modal-
ities like tDCS can be used to modulate en-
docannabinoids.  
tDCS is a neuromodulatory technique 
which has been widely used over the past 17 
years (Fregni et al., 2015). This popularity is 
for being non-invasive and painless, as well 
as having no or minimum side effects along 
with its affordability and operational sim-
plicity (Bastani and Jaberzadeh, 2012; 
Nitsche and Paulus, 2000). tDCS exerts its 
modulatory properties through facilitating 
(depolarization) or inhibiting (hyperpolariza-
tion) as well as adjusting excitability (in-
creasing/decreasing cortical excitability) of 
nerve cell membrane in target brain regions, 
therefore by priming the behavioural sys-
tems, tDCS can produce agreeable changes 
in the cognitive systems (Miniussi et al., 
2013). Also cathodal stimulation of the left 
Dorso-Lateral Prefrontal Cortex (DLPFC) in 
the humans, have inhibitory effect on fear 
memory consolidation (Asthana et al., 2013). 
It seems that not only polarity but also cur-
rent flow direction affect the tDCS stimula-
tion outcomes, for instance a study proposed 
that specific montage for tDCS (anode over 
right prefrontal region while cathode over 
left supraorbital region) increased fear mem-
ories in humans, probably by affecting the 
prefrontal cortex-amygdala circuit (Mungee 
et al., 2014). In another study anodal tDCS 
over the left DLPFC significantly decreased 
attentional bias for social threat;this atten-
tional bias is related to social anxiety disor-
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der (SAD), hence the authors recommended 
tDCS as an advanced method to investigate 
SAD mechanisms (Heeren et al., 2016), fur-
thermore, in other study tDCS over DLPFC 
caused significant reduction of vigilance to-
ward threatening stimulus; which was as ef-
fective as anxiolytic treatments. These re-
sults showed that tDCS over DLPFC could 
strongly change the processing of threat data 
(Ironside et al., 2016). All above findings 
highlighted the importance of prefrontal 
(prominent brain region for emotion and at-
tention processing) activity modulation for 
treating fear related diseases. 
The aim of this study was to investigate 
the effects of tDCS on fear memory respons-
es caused by selective cannabinoid CB1 re-
ceptor agonist (ACPA), both in short- and 
long-term. Recently, these two modalities 
have been considered seriously as a novel 
treatment of fear-related conditions.  
 
MATERIALS AND METHOD 
Animals 
This study was designed in such a way to 
lessen the number of subjects and their suf-
fering (Nasehi et al., 2016a). Subjects were 
sixty four male NMRI mice their suffering 
(Nasehi et al., 2016a). Subjects were sixty-
four male NMRI mice weighting 28-32 gr 
and were acquired from animal house of the 
Institute for Cognitive Science Studies; Teh-
ran - Iran. The study procedures were per-
formed in the room temperature (22 ± 2° C) 
and at 12 h/12 h light/dark cycle (lights 
turned on at 7:00 A.M.), also subjects had 
free access to food and water. One hour prior 
to starting experiment, subjects were trans-
ferred to experiment room undisturbed. 
The experiment procedures were ap-
proved by Tehran University of Medical Sci-
ences ethical committee and were in accord-
ance with the National Institutes of Health 
Publication No.85-23, revised. 2010, Animal 
Care and Use of Laboratory Animals guide-
lines. 
 
Drug 
ACPA (Arachidonylcyclopropylamide; 
Tocris, Cookson Ltd., UK), a selective can-
nabinoid CB1 receptor agonist, was dis-
solved in anhydrous ethanol at a concentra-
tion of 5 mg/ml and was diluted by normal 
saline to achieve the required doses. The 
drug was injected intraperitoneally at doses 
of 0.01, 0.05 and 0.1 mg/kg.  
 
Surgery 
Ketamine (50 mg/kg) and xylazine 
(5 mg/kg) were injected intraperitoneally to 
anesthetize the subjects. Their skulls were 
uncovered after they were secured in stereo-
taxic equipment, then anodal electrode with a 
2.1 mm internal diameter and capacity to 
provide 3.5 mm2 effective contact area 
(Pedron et al., 2014) was fixed over the right 
frontal region by dental cement. The corre-
sponding area for right frontal region was 
1 mm anterior and 1 mm to the right of 
Bregma (Paxinos and Franklin, 2004). After 
surgery, all subjects were allowed five days 
of recovery time. 
 
Transcranial brain stimulation 
In order to avoid anesthetizing the sub-
jects during tDCS, a custom made device 
was used to confine them and therefore ex-
clude the interference effects of anesthetic 
drugs on stimulation. The anode was planted 
over the right frontal region, and the cathode 
which was 9.5 cmଶ carbon rubber in the 
soaked sponge cover was placed under the 
subject's chest. This setup allowed us to 
avoid electrical current diversion (Liebetanz 
et al., 2009) and to maintain the safety and 
efficiency of the stimulation. Active Dose II 
unit (Activatek company-Taiwan) was used 
for tDCS, moreover, all groups were stimu-
lated at the same time of the stimulation day, 
which was one day before fear conditioning 
train. Control group received sham tDCS. 
tDCS group subjects were sacrificed, after 
that their brain were excavated and sliced by 
vibroslicer and then the acquired slices were 
examined under microscope, no abnormali-
ties were noticed. 
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Fear conditioning  
Fear conditioning method was achieved 
on basis of our earlier studies, (Nasehi et al., 
2016b, c; Shoji et al., 2014). An acoustic in-
sulated chamber with the dimensions of 55 × 
53× 67 cm3, which illuminated by 24 watts 
bulb and equipped with two speakers and a 
video camera was used for fear conditioning. 
In the training phase, subjects were placed in 
a transparent 25 cm3 plexiglass container 
with a shock mesh on its floor. The subjects 
were permitted to search the area freely for 
120 seconds, after that, the tone conditional 
stimulus (CS) with a 4 kHz frequency and 35 
dB intensity was transmitted for 30 seconds, 
and during its last 2 seconds the subjects 
were exposed to a foot shock with 1 mA in-
tensity and 50 Hz frequency as an uncondi-
tional stimulus (US). The subjects were al-
lowed to stay in the container for extra 30 
seconds to prevent their handling, affecting 
the associative memory, which has just been 
formed. In order to clean the container and 
rubbing out any cues, a 70 % ethanol solu-
tion was used after completion of the train-
ing and test, for each subject. 
In contextual associative memory test, 24 
hours after training, subjects were put in the 
same train area, for 300 seconds with no CS 
and US exposure. For auditory associative 
memory, one hour after contextual associa-
tive memory test, subjects were put in a 
completely different place to form a new 
context, the tone (CS) played for 3 minutes. 
The subjects’ responses to both tests were 
analyzed and scored by someone who had no 
information about the subject’s categories. 
Parameters which are related to fear and anx-
iety behaviors (Latency to freezing, freezing, 
grooming and rearing times) were examined.  
 
Experimental design 
Each group consisted of eight mice and 
was tested twice with fourteen days, time in-
terval. ACPA was administered intraperito-
neally (10 ml/kg) 15 minutes before training 
phase, while control groups received vehicle. 
Twenty four hours after training, contextual 
and auditory tests were performed (with one 
hour interval). 
 
Data analysis 
SPSS version. 19 was used for statistical 
analysis, one- or two-way analysis of vari-
ance (ANOVA) and repeated measure were 
used to evaluate our results. In combination 
studies, two-way ANOVA was performed 
with four levels (0, 0.01, 0.05 and 
0.1 mg/kg) of the ACPA as intra-group, and 
two levels of, without tDCS and with tDCS 
as inter-group factors. The repeated measure 
was performed between test and retest. We 
implemented tukey post hoc test for dual 
group assessments. The level of significancy 
was P < 0.05 in all experimental results.  
 
RESULTS 
Short-term and long-term effects of ACPA 
on the context-and-tone related fear 
memory acquisition 
The repeated measure and Tukey's post 
hoc analysis indicated that at all adminis-
tered doses of ACPA only 0.1 mg/kg re-
duced % freezing time and increased latency 
to the freezing in the short-term, meanwhile 
the % grooming time and % rearing time 
showed no significant differences for contex-
tual fear memory acquisition in both short- 
and long-term (Figure 1, panels 1 and 2). 
In auditory memory acquisition, 0.05 and 
0.1 mg/kg doses of ACPA showed decreased 
% freezing time and increased latency to 
freezing in short-term (Figure 2, panels 1 and 
2). % Grooming time and % rearing time did 
not change for both short- and long-term.  
To sum up, the data showed that ACPA 
had only short-term effect on both contextual 
and auditory fear memories and had no effect 
on grooming and rearing behaviors. All sta-
tistical analysis data have been shown in the 
Table 1. 
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Figure 1: Short-term and long-term effects of ACPA in absence or presence of right frontal tDCS on 
memory acquisition in the context-dependent fear conditioning. The animal received tDCS one day be-
fore training and vehicle (10 ml/kg) or different doses of ACPA (0.01, 0.05 and 0.1 mg/kg) 15 minutes 
prior to training. The test session was performed 1 and 15 days after the training (14 days interval). 
% freezing (A), latency to the freezing (B), % grooming time (C) and % rearing time (D).  
Values are expressed as mean ± S.E.M (n = 8 in each group). ** P < 0.01 and *** P < 0.001 different from control group in the 
panel 1. Ψψ P < 0.001 different from the control group in the panel 3. Φ P < 0.05, φφ P < 0.01 and φφφ P < 0.001 different from 
control group in the panel 4. 
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Figure 2: Short-term and long-term effects of ACPA in absence or presence of right frontal tDCS on 
memory acquisition in the auditory-dependent fear conditioning. The animals received tDCS one day 
before training and vehicle (10 ml/kg) or different doses of ACPA (0.01, 0.05 and 0.1 mg/kg) 15 
minutes prior to training. The test session was performed 1 and 15 days after the training (14 days in-
terval). % freezing (A), latency to the freezing (B), % grooming time (C) and % rearing time (D).  
Values are expressed as mean ± S.E.M (n = 8 in each group). * P < 0.05 and ** P < 0.01 different from control group in the pan-
el 1. Φ P < 0.05, φφ P < 0.01 and φφφ P < 0.001 different from control group in the panel 4. 
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Table 1: Repeated measure analysis with P values for the effect of ACPA on fear memory 
Experiments Behaviors Dose effect Time effect Dose×Time effect 
Final results 
conclusion for each 
experiment 
Repeated measure 
analysis and tukey’s 
post-hoc results for in-
traperitoneal ACPA in-
jection in contextual 
fear memory  
(between panels 1 and 
2 of Figure 1) 
 F(3,24) P F(1,24) P F(3,24) P 
0.1 mg/kg of ACPA im-
pair contextual fear 
memory in the short- 
term and had no effect 
on anxiety indicator 
behaviors ( % Groom-
ing and % Rearing) 
% Freezing 
time 7.111 0.001 21.926 0.0005 4.006 0.019 
Latency to 
Freezing 6.166 0.003 24.571 0.0005 1.621 0.211 
% Grooming 
time 0.708 0.557 0.001 0.986 0.396 0.757 
% Rearing 
time 1.018 0.402 0.478 0.496 1.443 0.255 
Repeated measure 
analysis and tukey’s 
post-hoc results for in-
traperitoneal ACPA in-
jection in auditory fear 
memory  
(between panels 1 and 
2 of Figure 2) 
 F(3,24) P F(1,24) P F(3,24) P 
0.05 and 0.1 mg/kg of 
ACPA impair auditory 
fear memory in the 
short-term and had no 
effect on anxiety indi-
cator behaviors 
(% Grooming and 
% Rearing) 
% Freezing 
time 4.526 0.012 4.238 0.051 3.685 0.026 
Latency to 
Freezing 1.830 0.169 0.873 0.359 1.677 0.198 
% Grooming 
time 1.341 0.285 1.130 0.298 1.090 0.372 
% Rearing 
time 0.268 0.848 0.134 0.717 2.338 0.099 
 
 
Effects of right frontal anodal tDCS on the 
ACPA-induced behaviors in short-term 
The two-way ANOVA and post hoc 
analysis showed that in contextual fear 
memory (Figure 1, panel 3), right frontal an-
odal tDCS in subthreshold doses of ACPA 
(0.01 and 0.05 mg/kg) increased % freezing 
time significantly, but it had no effect on ef-
fective dose of ACPA (0.1 mg/kg).  
Similar analysis indicated that right 
frontal anodal tDCS had no effect on latency 
to freezing and % grooming time (Figure 1, 
panel 3) for the contextual states induced by 
ACPA. 
Furthermore, right frontal anodal tDCS 
decreased % rearing time induced by ACPA 
(0.01 mg/kg) in the contextual (Figure 1, 
panel3) states. 
In auditory fear memory no significant 
changes were seen for all evaluated parame-
ters in short-term.  
In conclusion all data indicated that right 
frontal anodal tDCS in applied intensity did 
not affect both contextual and auditory fear 
memory formation by itself. Although this 
intervention did not restore memory acquisi-
tion deficit induced by effective dose of AC-
PA (0.1 mg/kg), but it did interestingly en-
hance memory in subthreshold doses of AC-
PA (0.01 and 0.05 mg/kg) in short-term. All 
statistical analysis data have been shown in 
the Table 2. 
 
Effects of right frontal anodal tDCS on the 
ACPA-induced behaviors in long-term 
Contextual effects 
Two-way ANOVA followed by post hoc 
analysis showed that right frontal anodal 
tDCS increased % freezing time in all ACPA 
doses (0.01 ,0.05 and 0.1 mg/kg), while de-
creased latency to freezing at 0.05 and 
0.1 mg/kg doses. tDCS decreased % rearing 
time at 0.1 mg/kg dose, while did not alter 
% grooming time (Figure 1, panel4) in long-
term state.  
In conclusion right frontal anodal tDCS 
alone, in long term is not effective in all in-
vestigated behaviours. It also noted that right 
frontal anodal tDCS increased % freezing 
time and decreased latency to freezing and 
% rearing time, while did not alter % groom-
ing time changes induced by ACPA. 
Auditory effects 
Two-way ANOVA followed by post hoc 
analysis showed that right frontal anodal 
EXCLI Journal 2017;16:1-13 – ISSN 1611-2156 
Received: October 08, 2016, accepted: December 05, 2016, published: January 02, 2017 
 
 
8 
tDCS increased % freezing time and de-
creased latency to freezing (in all adminis-
tered doses of ACPA), but it increased 
% grooming time (at dose of 0.01 mg/kg), 
while it did not alter % rearing time in the 
long-term state (Figure 2, panel4).  
It is noteworthy that right frontal anodal 
tDCS in long-term increased % grooming 
time, but did not alter any other behaviours 
by itself. Moreover, this intervention not on-
ly could restore ACPA induced amnesia 
(0.1 mg/kg) but also could enhance memory 
formation in subthreshold doses of ACPA 
(0.01 and 0.05 mg/kg). All statistical analy-
sis data have been shown in the Table 3. 
 
DISCUSSION 
ACPA effects on fear memory formation 
This study might be the first study that 
investigated long-term effects of ACPA on 
fear memory formation. Our data showed 
that pre-train injection of ACPA (i.p.) im-
paired contextual (0.1 mg/kg) and auditory 
(0.05, 0.1 mg/kg) fear memories in short-
term (in line with earlier studies), but in 
long-term no effect was seen in all adminis-
tered doses of ACPA. It has been shown that 
the cannabinoids caused inhibition of amyg-
dala neurons firing during formation of 
short-term memory (Wilson and Nicoll, 
2002) and as one of the well-known and ac-
cepted categories of retrograde messengers 
in the brain cannabinoids had numerous roles 
on short-term regulation of synaptic trans-
mission (Alger, 2002). Also it has been re-
ported that CB1 mediated fear inhibition 
through GABA and GABAergic plasticity 
(Kamprath et al., 2011) moreover, the func-
tional interaction between CB1 and chole-
cystokinin B receptor (CCKBR) which were 
closely located in the basolateral amygdala 
(BLA is a critical emotional regulation re-
gion) had a vital role in fear extinction pro-
cesses (Bowers and Ressler, 2015). Howev-
er, some studies indicated that ACPA im-
pairing effects on emotional memory could 
be via activation and deactivation of BLA 
serotonin 5-HT3 and 5-HT4 receptors 
(Chegini et al., 2014) and also could be re-
lated to NMDA receptors activation in cen-
tral amygdala (Ghiasvand et al., 2011). 
 
Table 2: Two-way ANOVA results for the effect of tDCS prior to ACPA injection on fear memory in 
short-term 
Experiments Behaviors Dose effect Time effect Dose×Time effect 
Final results conclu-
sion for each experi-
ment 
Two-way ANOVA and 
post-hoc analysis re-
sults for applying tDCS 
prior to intraperitoneal 
ACPA injection on con-
textual fear memory in 
the short-term (be-
tween panels 1 and 3 
of Figure 1) 
 F(3,56) P F(1,56) P F(3,56) P Right anodal tDCS had 
no effects on contextu-
al fear memory by itself  
and it cannot restore 
memory deficit induced 
by effective dose of 
ACPA (0.1 mg/kg) but 
it can enhance memory 
in subthreshold doses 
of ACPA 0.01  &0.05 ) 
in the short-term 
% Freezing 
time 12.751 0.0005 15.888 0.0005 6.501 0.001 
Latency to 
Freezing 8.835 0.0005 4.156 0.0005 1.013 0.395 
% Grooming 
time 1.368 0.079 11.581 0.001 0.069 0.976 
% Rearing 
time 5.323 0.003 9.718 0.003 4.127 0.011 
Two-way ANOVA and 
post-hoc analysis re-
sults for applying tDCS 
prior to intraperitoneal 
ACPA injection on au-
ditory fear memory in 
the short-term (be-
tween panels 1 and 3 
of Figure 2) 
 F(3,56) P F(1,56) P F(3,56) P 
Right anodal tDCS had 
no effects on auditory 
fear memory either  by 
itself or with all applied  
doses of ACPA in the 
short-term 
% Freezing 
time 3.709 0.018 1.655 0.204 1.112 0.350 
Latency to 
Freezing 0.683 0.567 0.040 0.843 1.921 0.139 
% Grooming 
time 0.804 0.498 0.027 0.870 0.864 0.466 
% Rearing 
time 3.374 0.026 0.547 0.463 0.391 0.760 
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Table 3: Two-way ANOVA results for the effect of tDCS prior to ACPA injection on fear memory in 
long-term 
Experiments Behaviors Dose effect Time effect Dose×Time ef-fect 
Final results conclu-
sion for each exper-
iment 
Two-way ANOVA and 
post-hoc analysis re-
sults for applying 
tDCS prior to intraperi-
toneal ACPA injection 
on contextual fear 
memory in the long-
term (between panels 
2 and 4 of Figure 1) 
 F(3,56) P F(1,56) P F(3,56) P 
In the long-term tDCS 
had no effect on con-
textual fear memory 
alone but it can re-
store and enhance 
contextual memory in 
all ACPA administered 
doses 
% Freezing 
time 8.745 0.0005 63.039 0.0005 9.712 0.0005 
Latency to 
Freezing 4.948 0.005 46.711 0.0005 5.398 0.003 
% Grooming 
time 0.452 0.717 2.802 0.101 1.249 0.302 
% Rearing 
time 0.814 0.493 15.760 0.0005 1.524 0.220 
Two-way ANOVA and 
post-hoc analysis re-
sults for applying 
tDCS prior to intraperi-
toneal ACPA injection 
on auditory fear 
memory in the long-
term (between panels 
2 and 4 of Figure 2) 
 F(3,56) P F(1,56) P F(3,56) P 
In the long-term tDCS 
had no effect on audi-
tory fear memory 
alone but it can re-
store and enhance 
auditory memory in all 
ACPA administered 
doses 
% Freezing 
time 6.063 0.001 69.947 0.0005 7.194 0.0005 
Latency to 
Freezing 2.947 0.042 26.254 0.0005 4.378 0.008 
% Grooming 
time 5.007 0.004 13.147 0.001 4.390 0.008 
% Rearing 
time 0.801 0.499 11.749 0.001 1.561 0.211 
 
 
tDCS effects on fear memory formation 
According to our results right frontal an-
odal tDCS (0.2 mA for 20 min) in the short-
term had no significant effect on fear 
memory formation (contextual and auditory), 
but conversely in the long-term enhanced 
both fear memories. Furthermore, grooming 
and rearing behaviors as anxiogenic indices 
did not change, so we could say that tDCS 
protocol had no anxiogenic effects. 
There were studies showed that tDCS 
could enhance glutamatergic plasticity in 
both animals and humans directly [via modu-
lation of neuronal calcium inflow (Nitsche et 
al., 2003)] and indirectly [via reducing 
GABA (Stagg et al., 2009)]. It was suggested 
that tDCS caused neuroplasticity for main-
taining homeostasis (Medeiros et al., 2012) 
by regulating variety of neurotransmitters 
such as dopamine, acetylcholine, and seroto-
nin (Kuo et al., 2007, 2008; Monte-Silva et 
al., 2009). 
Our findings showed that long-term 
memory enhancement occurred as a result of 
lasting LTP and durable learning and 
memory enhancement. This finding was co-
herent with earlier studies that have shown 
durable hippocampal synaptic plasticity 
could be reached by using tDCS (Rohan et 
al., 2015) and even one exposure could be 
sufficient for learning new associative 
memory and behavioral patterns (Pasupathy 
and Miller, 2005; Schultz et al., 2003). 
 
tDCS plus ACPA effects on fear memory 
formation 
The effect of preconditioning with tDCS 
on fear memory responses induced by ACPA 
was also investigated. tDCS restored the 
contextual amnesia induced by subthreshold 
doses of ACPA (0.01 and 0.05 mg/kg) in 
short-term, while improved fear memory 
formation by all applied doses of ACPA in 
long-term in both contextual and auditory 
fear memories formation. % Grooming and 
% rearing times mostly showed no signifi-
cant changes (except for % grooming time in 
long-term auditory fear memory in tDCS 
alone and in tDCS with 0.01 mg/kg ACPA 
groups), thus we could conclude that our 
method did not cause anxiety-like behaviors. 
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Earlier findings suggested that synaptic 
plasticity was the underlying mechanism for 
different types of memory (Malenka and 
Nicoll, 1999), also the endocannabinoids in-
volvement in short-term (Wilson and Nicoll, 
2001) and long-term synaptic plasticity were 
shown (Melis et al., 2004; Zygmunt et al., 
2000). Our results could be explained by Lin 
et al. (2011) findings that high-frequency 
(HFS) and theta-burst stimulations induced 
long-term depression of ȣ-aminobutyric acid 
(GABA) transmission by endocannabinoids, 
this induction intensely affected the excitato-
ry postsynaptic potential through metaplas-
ticity. Furthermore, Cui and others (2015) 
found out that eCB is a bidirectional plastici-
ty system which could cause rapid learning, 
depending on synaptic state. On the other 
hand, changing the state of synapse by pre-
conditioning with tDCS can alter the ex-
pected effects of other modalities such as 
rTMS (Quartarone et al., 2005; Siebner et 
al., 2004).  
Different results in short-term contextual 
and auditory fear memories could be related 
to various pathways of these two fear memo-
ries, for instance vital involvement of dorsal 
hippocampus in contextual fear memory 
formation and retrieval (Maren et al., 2013; 
Zhou et al., 2016) and also dissimilar amyg-
dala nuclei participation in the contextual 
[basolateral and basomedial amygdala 
(Maren and Fanselow, 1995)] and in the au-
ditory [lateral amygdaloid nucleus (Doron 
and Ledoux, 1999; LeDoux et al., 1991)] 
fear memories. 
Our data suggested that fear circuit had 
homeostatic system. It has shown that home-
ostatic systems follow regulatory mecha-
nisms for preserving stability by keeping 
neuron activity in functional dynamic range 
(Sejnowski, 1977). Understanding these 
mechanisms which can broaden the usage of 
tDCS in clinic needs more in-depth investi-
gation. 
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